Ulrich Steidl Selected Research

pegfilgrastim (Neulasta)

10/2006	Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.
2/2006	A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrich Steidl Research Topics

Disease

31	Neoplasms (Cancer) 02/2024 - 07/2002
24	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 06/2005
16	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 01/2007
14	Leukemia 02/2024 - 06/2005
6	Thrombocytopenia (Thrombopenia) 10/2020 - 10/2009
4	Primary Myelofibrosis (Myelosclerosis) 11/2023 - 01/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 11/2017
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2006 - 08/2004
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2002
3	Multiple Myeloma 01/2018 - 02/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 10/2012
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 06/2023 - 01/2019
2	Adenocarcinoma 01/2022 - 07/2010
2	Carcinogenesis 01/2022 - 12/2006
2	Anemia 10/2021 - 02/2011
2	Neutropenia 10/2021 - 10/2006
2	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2010
2	Bone Marrow Failure Disorders 12/2018 - 02/2011
2	Disease Progression 01/2017 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 04/2010
2	Polycythemia Vera 02/2013 - 04/2010
2	Lung Neoplasms (Lung Cancer) 12/2006 - 01/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2006 - 01/2006
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023
1	Hypotension (Low Blood Pressure) 10/2021
1	Chromosome Breakage 01/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Necrosis 01/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019

Drug/Important Bio-Agent (IBA)

7	eltrombopag FDA Link 01/2023 - 10/2009
6	proto-oncogene protein Spi-1IBA 01/2019 - 01/2006
6	Transcription Factors (Transcription Factor)IBA 11/2017 - 06/2005
5	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2017
3	Interleukin-1 Receptor Accessory ProteinIBA 07/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2011
3	ChromatinIBA 01/2021 - 11/2017
3	CytosineIBA 01/2019 - 01/2017
3	5-hydroxymethylcytosineIBA 01/2019 - 09/2013
3	Thrombopoietin ReceptorsIBA 12/2018 - 10/2009
3	Formaldehyde (Formol)FDA Link 11/2006 - 01/2005
3	ParaffinIBA 11/2006 - 01/2005
2	Immunotoxins (Immunotoxin)IBA 02/2024 - 10/2012
2	Lenalidomide (CC 5013)FDA Link 01/2023 - 12/2014
2	CateninsIBA 12/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 12/2019 - 10/2006
2	LY-2157299IBA 12/2019 - 02/2011
2	Janus Kinase InhibitorsIBA 01/2019 - 04/2010
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2019
2	IronIBA 12/2018 - 07/2012
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2015 - 02/2015
2	LigandsIBA 03/2011 - 01/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2006 - 08/2004
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2006 - 01/2005
2	fragile histidine triad proteinIBA 11/2006 - 01/2005
2	pegfilgrastim (Neulasta)FDA Link 10/2006 - 02/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2006 - 02/2006
1	Sialic Acid Binding Ig-like Lectin 2IBA 02/2024
1	AntibodiesIBA 02/2024
1	Chimeric Antigen ReceptorsIBA 02/2024
1	Monoclonal AntibodiesIBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	LipidsIBA 06/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2023
1	d,d-T80-prallethrin (ETOC)IBA 06/2023
1	Ribosomal Proteins (Ribosomal Protein)IBA 06/2023
1	GlutaminaseIBA 02/2023
1	Glutamine (L-Glutamine)FDA Link 02/2023
1	Azacitidine (5 Azacytidine)FDA Link 02/2023
1	PurinesIBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2022
1	CA-4948IBA 01/2022
1	Peptides (Polypeptides)IBA 10/2021
1	Alkaline PhosphataseIBA 10/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019
1	Aurora Kinase AIBA 01/2019
1	Trans-Activators (Trans-Acting Factor)IBA 01/2019
1	p21-Activated KinasesIBA 01/2019
1	PF 3758309IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Chelating AgentsIBA 12/2018
1	CarcinogensIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 11/2017
1	A-Form DNA (A-DNA)IBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	CytokinesIBA 01/2017
1	CalreticulinIBA 04/2016
1	p38 Mitogen-Activated Protein KinasesIBA 01/2016
1	pexmetinibIBA 01/2016

Therapy/Procedure

17	Therapeutics 02/2024 - 12/2003
2	Stem Cell Transplantation 06/2023 - 10/2006
2	Drug Therapy (Chemotherapy) 10/2019 - 10/2006
2	Transplantation 12/2017 - 05/2004
1	Immunotherapy 02/2024